EP PerMed – European Partnership for Personalized Medicine

EP PerMed's vision is to improve health outcomes within sustainable healthcare systems through research, development, innovation, and implementation of personalized medicine approaches for the benefit of patients, citizens, and society. This partnership promotes the joint programming of activities to support national and European research and innovation that put the Strategic Research and Innovation Agenda for Personalized Medicine into action through dedicated funding for research, development, and innovation.

Personalized medicine is broadly understood as a medical model that uses the characterization of people's phenotypes and genotypes (e.g., molecular characterization, medical imaging, lifestyle data) to tailor therapeutic strategies to each person at the right time, and/or to determine predisposition to disease, and/or to provide timely and appropriately targeted preventive care (according to theconclusions of the Council of the European Union on personalized medicine for patients – 2015/C 421/03).

EP PerMed brings together 62 institutions, including ministries, funding organizations, and research institutes from 29 countries, and builds on the results and experience of various international initiatives and projects in the field of personalized medicine, as well as on more than 15 years of successful collaboration between many of the partners involved.

The FCT, the Agency for Clinical Research and Biomedical Innovation, the Regional Coordination and Development Commission of the Center, and the Vice-Presidency of the Regional Government of the Azores, through the Regional Directorate for Science, Innovation, and Development, are the Portuguese organizations that are part of EP PerMed.

This initiative has received funding from the European Union's Horizon Europe Research and Innovation Program, Grant Agreement No. 101137129.